A decade of immune-checkpoint inhibitors in cancer therapy

التفاصيل البيبلوغرافية
العنوان: A decade of immune-checkpoint inhibitors in cancer therapy
المؤلفون: Caroline Robert
المصدر: Nature Communications
Nature Communications, Vol 11, Iss 1, Pp 1-3 (2020)
بيانات النشر: Nature Publishing Group UK, 2020.
سنة النشر: 2020
مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Science, medicine.medical_treatment, Immune checkpoint inhibitors, Programmed Cell Death 1 Receptor, Cancer therapy, General Physics and Astronomy, Cancer immunotherapy, 02 engineering and technology, Antibodies, Monoclonal, Humanized, General Biochemistry, Genetics and Molecular Biology, B7-H1 Antigen, 03 medical and health sciences, Antineoplastic Agents, Immunological, Internal medicine, Neoplasms, medicine, Humans, CTLA-4 Antigen, Clinical efficacy, lcsh:Science, Multidisciplinary, biology, business.industry, Comment, Cancer, Antibodies, Monoclonal, General Chemistry, Immunotherapy, 021001 nanoscience & nanotechnology, medicine.disease, Ipilimumab, 030104 developmental biology, Nivolumab, Toxicity, Monoclonal, biology.protein, Tumour immunology, lcsh:Q, Antibody, 0210 nano-technology, business
الوصف: Immunotherapy using immune-checkpoint modulators revolutionizes the oncology field far beyond their remarkable clinical efficacy in some patients. It creates radical changes in the evaluation of treatment efficacy and toxicity with a more holistic vision of the patient with cancer.
اللغة: English
تدمد: 2041-1723
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbaf2f8ae9ec128dbeaf95d89fd1c645Test
http://europepmc.org/articles/PMC7393098Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....dbaf2f8ae9ec128dbeaf95d89fd1c645
قاعدة البيانات: OpenAIRE